FDA, Industry To Iron Out Branding Provision Concerns Under MDUFMA
This article was originally published in The Gray Sheet
Executive Summary
Implementation of device branding practices that are cost-effective and do not compromise safety and efficacy will require administrative solutions generated by manufacturers and FDA, according to Latham & Watkins Associate John Manthei